ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
1-Year Return
8.06%
This Quarter Return
-4.87%
1 Year Return
-8.06%
3 Year Return
+35.07%
5 Year Return
+60.97%
10 Year Return
–
AUM
$362M
AUM Growth
-$26.9M
(-6.9%)
Cap. Flow
-$2.52M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
32.46%
Holding
471
New
47
Increased
54
Reduced
92
Closed
46
Top Buys
| 1 |
Adobe
ADBE
|
$531K |
| 2 |
PayPal
PYPL
|
$414K |
| 3 |
FedEx
FDX
|
$233K |
| 4 |
Freeport-McMoran
FCX
|
$215K |
| 5 |
NVIDIA
NVDA
|
$200K |
Top Sells
| 1 |
Okta
OKTA
|
$1.32M |
| 2 |
Apple
AAPL
|
$428K |
| 3 |
IBM
IBM
|
$428K |
| 4 |
SPDR ICE Preferred Securities ETF
PSK
|
$231K |
| 5 |
Dover
DOV
|
$228K |
Sector Composition
| 1 | Technology | 22.52% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 12.9% |
| 4 | Consumer Staples | 12.61% |
| 5 | Energy | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
PayPal
PYPL
$65.2B
| $4.53M | 1.25% |
52,635
+4,812
| +10% | +$414K |
|
27
Stock Yards Bancorp
SYBT
$2.34B
| $4.26M | 1.17% |
62,565
-478
| -0.8% | -$32.5K |
|
28
Novartis
NVS
$251B
| $3.9M | 1.08% |
51,290
-312
| -0.6% | -$23.7K |
|
29
Altria Group
MO
$112B
| $3.66M | 1.01% |
90,593
-58
| -0.1% | -$2.34K |
|
30
Automatic Data Processing
ADP
$120B
| $3.49M | 0.96% |
15,437
-305
| -2% | -$69K |
|
31
Philip Morris
PM
$251B
| $3.49M | 0.96% |
42,056
-106
| -0.3% | -$8.8K |
|
32
Weyerhaeuser
WY
$18.9B
| $3.26M | 0.9% |
113,958
-2,352
| -2% | -$67.2K |
|
33
Alphabet (Google) Class C
GOOG
$2.84T
| $3.22M | 0.89% |
33,536
+1,476
| +5% | +$142K |
|
34
McCormick & Company Non-Voting
MKC
$19B
| $3.14M | 0.87% |
44,022
-225
| -0.5% | -$16K |
|
35
Coca-Cola
KO
$292B
| $2.94M | 0.81% |
52,391
-450
| -0.9% | -$25.2K |
|
36
ResMed
RMD
$40.6B
| $2.85M | 0.79% |
13,059
-624
| -5% | -$136K |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $2.7M | 0.74% |
9,312
| – | – |
|
38
Toronto Dominion Bank
TD
$127B
| $2.67M | 0.74% |
43,504
| – | – |
|
39
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.62M | 0.72% |
9,810
| – | – |
|
40
Edwards Lifesciences
EW
$47.5B
| $2.52M | 0.7% |
30,520
+1,594
| +6% | +$132K |
|
41
Roper Technologies
ROP
$55.8B
| $2.5M | 0.69% |
6,959
+472
| +7% | +$170K |
|
42
Estee Lauder
EL
$32.1B
| $2.45M | 0.68% |
11,363
-30
| -0.3% | -$6.48K |
|
43
Novo Nordisk
NVO
$245B
| $2.45M | 0.68% |
49,174
| – | – |
|
44
Seacoast Banking Corp of Florida
SBCF
$2.75B
| $2.38M | 0.66% |
78,799
-1,048
| -1% | -$31.7K |
|
45
Energy Transfer Partners
ET
$59.7B
| $2.37M | 0.65% |
214,990
-100
| -0% | -$1.1K |
|
46
Stryker
SYK
$150B
| $2.33M | 0.64% |
11,512
-183
| -2% | -$37.1K |
|
47
Hingham Institution for Saving
HIFS
$581M
| $2.22M | 0.61% |
8,827
-20
| -0.2% | -$5.02K |
|
48
Gilead Sciences
GILD
$143B
| $2.18M | 0.6% |
35,315
-1,677
| -5% | -$103K |
|
49
Thermo Fisher Scientific
TMO
$186B
| $2.12M | 0.58% |
4,172
+289
| +7% | +$147K |
|
|
50
Freeport-McMoran
FCX
$66.5B
| $1.99M | 0.55% |
72,896
+7,863
| +12% | +$215K |
|